Paid Clinical Trials in Winter Haven, FL
As of August 2026, 24 paid clinical trials are recruiting in Winter Haven, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Winter Haven offers studies at sites including Winter Haven Hospital for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Breast Cancer, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Winter Haven
Trials by drug in Winter Haven
Filter results
24 clinical trials
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Development and Analysis of a Stool Bank for Cancer Patients
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Top Research Study Locations in Winter Haven
Researchers run research studies in Winter Haven, FL at 9 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Winter Haven Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Breast Cancer | 12 |
| Center for Retina and Macular Disease | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Macular Edema | 4 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Baycare Health Systems Clearwater | Atrial Fibrillation | 1 |
| Bond Clinic | Non-Small Cell Lung Cancer | 1 |
| Bond and Steele Clinic, P.A. | Carcinoma, Colorectal, Carcinoma, Non-Small-Cell Lung | 1 |
| Center for Retina and Macular Disease (01026) | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Day Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Winter Haven Ambulatory Surgical Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Winter Haven (2026)
Recruiting trials in Winter Haven grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial · Phase 3 · National Cancer Institute (NCI)
Eye & vision (6 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Cardiovascular (2 active studies)
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS · Phase 3 · DalCor Pharmaceuticals
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
Diabetes & metabolic (1 active study)
Common conditions studied in Winter Haven
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Breast Cancer (2 active studies)
- Lung Non-Small Cell Carcinoma (2 active studies)
- Melanoma (2 active studies)
- Acute Coronary Syndrome (1 active study)
Leading research sponsors in Winter Haven
- NRG Oncology
- AbbVie
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Adverum Biotechnologies, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Winter Haven?
There are approximately 24 recruiting clinical trials in Winter Haven, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Winter Haven pay participants?
Most recruiting trials in Winter Haven compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Winter Haven?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Winter Haven?
The most common conditions under active study in Winter Haven include Anatomic Stage II Breast Cancer AJCC v8 (3), Anatomic Stage I Breast Cancer AJCC v8 (2), Breast Cancer (2), Lung Non-Small Cell Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Winter Haven?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Winter Haven on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Winter Haven?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Winter Haven?
Recruiting research sites in Winter Haven include Winter Haven Hospital, Center for Retina and Macular Disease, Adverum Clinical, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Winter Haven right now?
The largest active categories in Winter Haven are Cancer & tumors (12), Eye & vision (6), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.